Plausible Positive Effects of Statins in COVID-19 Patient-Reference-Cited by-同舟云学术

Plausible Positive Effects of Statins in COVID-19 Patient

Published:2021-07-13 Issue:10 Volume:21 Page:781-789
ISSN:1530-7905
Container-title:Cardiovascular Toxicology
language:en
Short-container-title:Cardiovasc Toxicol

Author:

Vitiello Antonio^ORCID,Ferrara Francesco^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology

Link

https://link.springer.com/content/pdf/10.1007/s12012-021-09674-x.pdf

Reference91 articles.

1. World health organization. (WHO). (2021). Retrieved April 2021 from, https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

2. Vitiello, A., & Ferrara, F. (2021). Therapeutic strategies for SARS-CoV-2 acting on ACE-2. European Journal of Pharmaceutical Sciences, 156, 105579. https://doi.org/10.1016/j.ejps.2020.105579

3. Vitiello, A., La Porta, R., & Ferrara, F. (2020). Sacubitril, valsartan and SARS-CoV-2. BMJ Evidence-Based Medicine. https://doi.org/10.1136/bmjebm-2020-111497

4. Vitiello, A., La Porta, R., & Ferrara, F. (2021). Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19. Medical Hypotheses, 147, 110486. https://doi.org/10.1016/j.mehy.2021.110486

5. Vitiello, A., & Ferrara, F. (2020). Remdesivir versus ritonavir/lopinavir in COVID-19 patients. Irish Journal of Medical Science. https://doi.org/10.1007/s11845-020-02440-y

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evaluation of Drugs as Potential Modulators of the Trafficking and Maturation of ACE2, the SARS-CoV-2 Receptor;Biomolecules;2024-06-27

2. Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19;Frontiers in Nutrition;2022-06-22

3. Atorvastatin: old friend in the light of novel coronavirus infection’s pandemia;Meditsinskiy sovet = Medical Council;2022-04-06

4. Muscle pain and muscle weakness in COVID19 patients: Cross-talk with statins – Preliminary results;Biomedicine & Pharmacotherapy;2022-04

5. Atorvastatin Reduces the Severity of COVID-19: A Nationwide, Total Population-Based, Case-Control Study;COVID;2022-03-16